Update on HIV in Western Europe

Current HIV/AIDS Reports

Volumn 11, Issue 2, 2014, Pages 177-185

  Nakagawa, Fumiyo ^a   Phillips, Andrew N ^a   Lundgren, Jens D ^b  

^a Research Department of Infection and Population Health   (United Kingdom)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Antiretroviral therapy; Europe; Global epidemic; HIV; HIV infection; HIV testing rates; HIV AIDS; State of the epidemic; Western Europe

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

AGING; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE SURVEILLANCE; EPIDEMIC; HARM REDUCTION; HEALTH CARE ACCESS; HEALTH CARE DISPARITY; HEPATITIS C; HETEROSEXUALITY; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRATION; INCIDENCE; INTRAVENOUS DRUG ABUSE; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; MORTALITY; PATIENT CARE; PREVALENCE; SEXUAL TRANSMISSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION; WESTERN EUROPE; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; DRUG USE; EPIDEMIOLOGY; EUROPE; FEMALE; HEALTH; HEALTH SURVEY; HIV INFECTIONS; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; PRISONER; PROSTITUTION; STATISTICS AND NUMERICAL DATA; TRANSMISSION; TRENDS; VERY ELDERLY; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-HIV AGENTS; DRUG USERS; EPIDEMICS; EUROPE; FEMALE; GLOBAL HEALTH; HETEROSEXUALITY; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; PRISONERS; SEX WORKERS; YOUNG ADULT;

EID: 84903579491     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-014-0198-8     Document Type: Article

References (76)

1. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global report: UNAIDS report on the global AIDS epidemic 2013. 2013.
2. Stover J. Projecting the demographic consequences of adult HIV prevalence trends: the Spectrum Projection Package. Sex Transm Infect. 2004;80 Suppl 1:i14-8. (Pubitemid 39070779)
3. Stover J, Brown T, Marston M. Updates to the Spectrum/Estimation and Projection Package (EPP) model to estimate HIV trends for adults and children. Sex Transm Infect. 2012;88 Suppl 2:i11-6.
4. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26(1):17-25.
5. •• Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the Global Burden of Disease Study 2010. AIDS. 2013;27(13):2003-17. A global study which evaluated by country, the burden of HIVinfection in terms of disability adjusted life years (DALYs) between 1980 and 2010.
6. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS Surveillance in Europe 2012. Stockholm: European Centre for Disease Prevention and Control; 2013.
7. UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance. Surveillance of the HIV/AIDS epidemic: a comprehensive package. October 2013. Geneva, Switzerland. http://www.who.int/hiv/pub/surveillance/2013package/en/ index.html. 2013.
8. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. HIV/AIDS surveillance in Europe 2011. Stockholm: European Centre for Disease Prevention and Control; 2012.
9. Herida M, Alix J, Devaux I, Likatavicius G, Desenclos JC, Matic S, et al. HIV/AIDS in Europe: epidemiological situation in 2006 and a new framework for surveillance. Euro Surveill 2007; 12(47).
10. Sonnenberg P, Clifton S, Beddows S, Field N, Soldan K, Tanton C, et al. Prevalence, risk factors, and uptake of interventions for sexually transmitted infections in Brita findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal). Lancet. 2013;382(9907):1795-806.
11. Vanden Berghe W, Nostlinger C, Buve A, Beelaert G, Fransen K, Laga M. A venue-based HIV prevalence and behavioural study among men who have sex with men in Antwerp and Ghent, Flanders, Belgium, October 2009 to March 2010. Euro Surveill 2011; 16(28).
12. Barin F, Nardone A. MonitoringHIVepidemiology using assays for recent infection: where are we? Euro Surveill 2008; 13(36).
13. • Garrett N, Lattimore S, Gilbart V, Aghaizu A, Mensah G, Tosswill J, et al. The Recent Infection Testing Algorithm (RITA) in clinical practice: a survey of HIV clinicians in England and Northern Ireland. HIV Med. 2012;13(7):444-7. Algorithms to estimate how recent the HIV infection occurred are increasingly used to estimate HIV incidence and to improve the understanding of transmission dynamics in concentrated epidemics. This study showed that informing patients of RITA results did not lead to adverse events.
14. Semaille C, Cazein F, Lot F, Pillonel J, Le Vu S, Le Strat Y, et al. Recently acquired HIV infection in men who have sex with men (MSM) in France, 2003-2008. Euro Surveill. 2009;14(48):5-8.
15. Vercauteren J, Wensing AMJ, van de Vijver DAMC, Albert J, Balotta C, Hamouda O, et al. Transmission of drugresistant HIV-1 is stabilizing in Europe. J Infect Dis. 2009;200(10):1503-8.
16. Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med. 2008;9:6-12. (Pubitemid 351819089)
17. Eldred L, Malitz F. Introduction [to the supplemental issue on the HRSA SPNS Outreach Initiative]. AIDS Patient Care STDS. 2007;21 Suppl 1:S1-2.
18. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493-505.
19. Loutfy MR, Wu W, Letchumanan M, Bondy L, Antoniou T, Margolese S, et al. Systematic review of HIV transmission between heterosexual serodiscordant coupleswhere the HIV-positive partner is fully suppressed on antiretroviral therapy. PLoS One. 2013;8(2): e55747.
20. Delpech V, Brown A, Conti S, Polavarapu V, Yin Z. Reducing onward transmission: Viral suppression among key population groups living with HIV in the United Kingdom. 19th Annual Conference of the British HIVAssociation (BHIVA). Manchester, UK. Abstract# O18. 2013.
21. Supervie V, Costagliola D. The spectrum of engagement in HIV care in France: strengths and gaps. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, USA: March 2013. Abstract#1030. 2013.
22. Helleberg M, Häggblom A, Sönnerborg A, Obel N. HIV care in the Swedish-Danish HIV cohort 1995-2010. Closing the gaps. PLoS One. 2013;8(8):e72257.
23. Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS. 2012;26(7):893-6.
24. Brown A, Gill O, Delpech V. HIV treatment as prevention among men who have sex with men in the UK: is transmission controlled by universal access to HIV treatment and care? HIV Med. 2013;14(9):563-70.
25. Raben D, Delpech V, De WJ, Sullivan A, Lazarus J, Dedes N, et al. Conclusions fromthe HIVin Europe Copenhagen 2012 Conference and ways forward: working together for optimal HIV testing and earlier care. HIV Med. 2013;14 Suppl 3:1-5.
26. Gazzard B, Clumeck N,MonforteA, Lundgren J. Indicator diseaseguided testing for HIV - the next step for Europe? HIV Med. 2008;9:34-40. (Pubitemid 351819095)
27. • Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S, et al. Feasibility and effectiveness of indicator condition-guided testing for HIV: results from HIDES I (HIV indicator diseases across Europe study). PLoS One. 2013;8(1):e52845. Results from a study investigating a method to improve targeted HIV testing. The authors found that testing people presenting with one of eight indicator conditions/diseases to any healthcare setting was costeffective and should be encouraged.
28. Mounier-Jack S, Nielsen S, Coker RJ. HIV testing strategies across European countries. HIV Med. 2008;9:13-9. (Pubitemid 351819090)
29. European Centre for Disease Prevention and Control. HIV testing: increasing uptake and effectiveness in the European Union. Stockholm: ECDC; 2010.
30. Rayment M, Rae C, Ghooloo F, Doku E, Hardie J, Finlay S, et al. Routine HIV testing in the emergency department: tough lessons in sustainability. HIV Med. 2013;14:6-9.
31. Burns F, Edwards S, Woods J, Haidari G, Calderon Y, Leider J, et al. Acceptability, feasibility and costs of universal offer of rapid point of care testing for HIV in an acute admissions unit: results of the RAPID project. HIV Med 2013; 14:10-14.
32. Meulbroek M, Ditzel E, Saz J, Taboada H, Perez F, Perez A, et al. BCN Checkpoint, a community-based centre for men who have sex with men in Barcelona, Catalonia, Spain, shows high efficiency in HIV detection and linkage to care. HIV Med. 2013;14:25-8.
33. RaymentM, Doku E, Thornton A, PearnM, SudhanvaM, Jones R, et al. Automatic oral fluid-based HIV testing in HIV screening programmes: automatic for the people. HIV Med. 2013;14:49-52.
34. • Ng OT, Chow AL, Lee VJ, Chen MI, Win MK, Tan HH, et al. Accuracy and user-acceptability of HIV self-testing using an oral fluid-based HIV rapid test. PLoS One. 2012;7(9):e45168. The OraQuick ADVANCE RapidHIV 1/2 Antibody Test had a specificity of 99.9%and sensitivity of 97.4%in 994 people using self-tests for the first time. Results from this study supports making self-tests widely available.
35. Deblonde J, De Koker P, Hamers FF, Fontaine J, Luchters S, Temmerman M. Barriers to HIV testing in Europe: a systematic review. Eur J Publ Health. 2010;20(4):422-32.
36. Hamill M, Burgoine K, Farrell F, Hemelaar J, Patel G, Welchew DE, et al. Time to move towards opt-out testing for HIVin the UK. BMJ. 2007;334(7608):1352- 4. (Pubitemid 47041264)
37. Yazdanpanah Y, Lange J, Gerstoft J, Cairns G. Earlier testing for HIVhow do we prevent late presentation? Antivir Ther. 2010;15:17-24.
38. Adler A, Mounier-Jack S, Coker R. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care- Psychol Socio-Med Asp AIDS/HIV. 2009;21(3):284-93.
39. Antinori A, Coenen T, Costagiola D, Dedes N, Ellefson M, Gatell J, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61-4.
40. 3: assessment of need following changes in treatment guidelines. Clin Infect Dis. 2011;53(8):817-25.
41. •• Mocroft A, Lundgren JD, Sabin ML, Monforte AD, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PLoSMed. 2013;10(9):e1001510. Although late diagnosis has declined between 2000 and 2011 in Europe, it continues to be a significant problem across all HIV risk groups. Over half of people presenting in 2010/11 had a CD4 count low enough to require immediate HIV treatment.
42. European AIDS Clinical Society (EACS). EACS guidelines. October 2013. www.eacsociety.org. 2013.
43. Pérez-Molina JA, Pulido Ortega F. Assessment of the impact of the new health legislation on illegal immigrants in Spain: the case of human immunodeficiency virus infection. Enfermedades Infecciosas y Microbiolog+¡a Cl+¡nica. 2012;30(8):472-8.
44. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li CJ, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med. 2000;342(13):921-9. (Pubitemid 30177052)
45. Hofstra M, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al. Increasing number of HIV-1 diagnoses with transmitted drug resistance across Europe despite stable prevalence. 14th European AIDS Conference, Brussels, Belgium. Abstract PS2/1. 2013.
46. Health Protection Agency. HIV in the United Kingdom: 2012 Report. London: Health Protection Services, Colindale; 2012.
47. Stichting HIV Monitoring. Monitoring report 2012. Human Immunodeficiency Virus (HIV) Infection in the Netherlands. 2012.
48. Central Intelligence Agency (CIA). TheWorld Factbook. Accessed on 24th October at https://www.cia.gov/library/publications/the-world-factbook/ rankorder/2119rank.html. 2013.
49. European Centre for Disease Prevention and Control. Thematic report: Men who have sex with men. Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 Progress Report. Stockholm, Europe. 2013.
50. Bezemer D, deWolf F, BoerlijstMC, van SighemA,Hollingsworth T, PrinsM, et al.A resurgentHIV-1 epidemic amongmenwho have sex with men in the era of potent antiretroviral therapy. AIDS. 2008;22(9):1071-7. (Pubitemid 351769746)
51. Likatavicius G, Klavs I, Devaux I, Alix J, Nardone A. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: implications for a European public health strategy. Sex Transm Infect. 2008;84(6):499-505.
52. Sullivan PS, Hamouda O, Delpech V, Geduld JE, Prejean J, Semaille C, et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann Epidemiol. 2009;19(6):423-31.
53. • Phillips AN, Cambiano V, Nakagawa F, Brown AE, Lampe F, Rodger A, et al. Increased HIV Incidence in Men Who Have Sex with Men Despite High Levels of ART-Induced Viral Suppression: Analysis of an Extensively Documented Epidemic. PLoS One. 2013;8(2):e55312. Modelling study in MSM in the UK, which showed that despite high ART coverage, the HIV incidence among MSM in the UK has increased, although it would have been even higher if preventative measures/condom-use were less frequent.
54. World Health Organisation. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIVinfection. 2013.
55. The EMIS Network. EMIS 2010: The European men-who-have-sex- with-men internet survey. Findings from 38 countries. Stockholm: ECDC; 2013.
56. del Amo J, Likatavicius G, Pérez-Cachafeiro S, Hernando V, González C, Jarrín I, et al. The epidemiology of HIV and AIDS reports in migrants in the 27 European Union countries, Norway and Iceland: 1999-2006. Eur J Publ Health. 2011;21(5):620-6.
57. Aghaizu A, Brown AE, Nardone A, Gill ON, Delpech VC, contributors. HIV in the United Kingdom 2013 Report: data to end 2012. London: Public Health England; 2013.
58. European Centre for Disease Prevention and Control. Responses to HIV and migration in western industrialised countries: current challenges, promising practices, future directions. Stockholm: ECDC; 2013.
59. Alvarez-del Arco D, Monge S, Caro-Murillo AM, Ramírez-Rubio O, Azcoaga-Lorenzo A, Belza MJ, et al. HIV testing policies for migrants and ethnic minorities in EU/EFTA Member States. The European Journal of Public Health 2013
60. Hamers FF, DownsAM. HIVin central and eastern Europe. Lancet. 2003;361(9362):1035-44.
61. Beyrer C, Abdool Karim Q. The changing epidemiology of HIV in 2013. Curr Opin HIVAIDS. 2013;8(4):306-10.
62. Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP, et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010;375(9719):1014-28.
63. • Pharris A, Wiessing L, Sfetcu O, Hedrich D, Botescu A, Fotiou A, et al. Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Euro Surveill. 2011;16(48):14-8. Report on the recent rapid increase in cases of HIVamong people who inject drugs in Greece and Romania. The rise in incidence was observed following the financial crisis in 2008-9 which contributed to lower coverage of prevention services.
64. Joint EMCDDA and ECDC rapid risk assessment. HIVin injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania. 2012.
65. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. 2005;192(6):992-1002. (Pubitemid 41266795)
66. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012;55 suppl 1:S33-42.
67. European Collaborative Study. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS. 2006;20(10):1419-27.
68. Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22(8):973-81. (Pubitemid 351652248)
69. Bailey H, Townsend C, Cortina-Borja M, Thorne C. Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther. 2011;16(6):895-903.
70. Chiappini E, Galli L, Giaquinto C, Ene L, Goetghebuer T, Judd A, et al. Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European highrisk infants. AIDS. 2013;27(6):991-1000.
71. Lazarus JV, Juergens R, Weait M, Phillips A, Hows J, Gatell J, et al. Overcoming obstacles to late presentation for HIV infection in Europe. HIV Med. 2011;12(4):246-9.
72. Fakoya I, Reynolds R, Caswell G, Shiripinda I. Barriers to HIV testing for migrant black Africans in Western Europe. HIV Med. 2008;9:23-5. (Pubitemid 351819092)
73. Nachega JB, Morroni C, Zuniga JM, Sherer R, Beyrer C, Solomon S, et al. HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Phys AIDS Care (JIAPAC). 2012;11(3):172-8.
74. Lancet T. HIV testing in Greece: repeating past mistakes. Lancet. 2013;382(9887):102.
75. Health Consumer Powerhouse. The Euro HIV Index 2009: a reality check of public policy and best practice in 29 countries. 2009.
76. • WorkingGroup on Estimation of HIV Prevalence in Europe. HIVin hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV. AIDS. 2011;25(8): 1017-23. A review ofmethods currently in use to estimate the size of the undiagnosed fraction in HIV-infected populations.